G
G Mieli-Vergani
Researcher at University of Cambridge
Publications - 42
Citations - 2128
G Mieli-Vergani is an academic researcher from University of Cambridge. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 22, co-authored 42 publications receiving 1969 citations.
Papers
More filters
Journal ArticleDOI
Diagnosis and phenotypic classification of Wilson disease
Peter Ferenci,Karel Caca,Georgios Loudianos,G Mieli-Vergani,Stuart Tanner,Irmin Sternlieb,Michael L. Schilsky,Diane W. Cox,Frieder Berr +8 more
TL;DR: The Wilson disease gene ATP7B encodes a P‐type ATPase, an inherited autosomal recessive disorder of hepatic copper metabolism leading to copper accumulation in hepatocytes and in extrahepatic organs such as the brain and the cornea.
Journal ArticleDOI
Biliary Atresia: The King's College Hospital Experience (1974-1995)
TL;DR: The age at surgery has limited usefulness as a predictor of survival after portoenterostomy and certainly should not be used to dictate primary treatment.
Journal ArticleDOI
The Outcome of the Older (>100 Days) Infant With Biliary Atresia
Mark Davenport,V. Puricelli,P Farrant,Nedim Hadzic,G Mieli-Vergani,Bernard Portmann,Edward R. Howard +6 more
TL;DR: The potential for reasonable medium-term survival is present in about one third of infants 100 days or older coming to primary corrective surgery, and the authors continue to favor this option rather than subject all to transplant simply on the basis of age.
Journal ArticleDOI
Association between HLA and extrahepatic biliary atresia.
Themis Reverbel da Silveira,Francisco M. Salzano,Peter T. Donaldson,G Mieli-Vergani,Edward R. Howard,Alex P. Mowat +5 more
TL;DR: It is suggested that immunogenetic factors may play a role in determining susceptibility to EHBA, and the different HLA frequencies in those with and without anomalies lend support to the hypothesis that biliary atresia may be an etiologically heterogeneous disorder.
Journal ArticleDOI
Orthotopic liver transplantation reverses the adverse nutritional changes of end-stage liver disease in children.
R. I. G. Holt,E. Broide,Charles R. Buchanan,John P. Miell,A Baker,Alex P. Mowat,G Mieli-Vergani +6 more
TL;DR: End-stage liver disease has a more adverse effect on MAC, TSF, and SSF than on height and weight, but a marked and rapid improvement occurred post-OLT.